Merck Can't Save Patents In 1st Fed Circ. Pharma AIA Appeal
The Federal Circuit on Thursday affirmed inter partes review decisions invalidating many claims of four dietary supplement patents that a Merck KGaA unit accused biotech firm Gnosis of infringing, in the...To view the full article, register now.
Already a subscriber? Click here to view full article